Targeting Cancer Drug-Tolerant Persister Cells in Minimal Residual Disease

International Journal of Drug Discovery and Pharmacology · Published 2025-05-27 · DOI 10.53941/ijddp.2025.100011

Authors being retrieved — see the publisher record. https://doi.org/10.53941/ijddp.2025.100011

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2025

Related articles

EXPRESS: Circular RNAs as Next Generation Biomarkers for Minimal Residual Disease: Mechanistic Insights and Clinical Translation · Journal of Investigative Medicine · 2026 · Cites or is cited by this article
Coronary Microvascular Dysfunction: A Potential Intervention Strategy against Acute Myocardial Infarction · International Journal of Drug Discovery and Pharmacology · 2025 · Same journal
Inhibiting the Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Cascade in Cancer and the Heart: for Better or Worse, in Sickness and Health? · International Journal of Drug Discovery and Pharmacology · 2024 · Same journal
Brief Version of Chinese Society of Cardiology Guidelines on the Diagnosis and Treatment of Adult Fulminant Myocarditis · International Journal of Drug Discovery and Pharmacology · 2024 · Same journal
Rho/ROCK Pathway as a Therapeutic Target in Multiple Diseases · International Journal of Drug Discovery and Pharmacology · 2025 · Same journal
Integrins as Drug Targets in Vascular and Related Diseases · International Journal of Drug Discovery and Pharmacology · 2024 · Same journal
Ginsenoside Re Alleviates Oxidative Stress Damage and Ferroptosis in Pulmonary Fibrosis Mice by Regulating the Nrf2/Keap1/GPX4 axis · International Journal of Drug Discovery and Pharmacology · 2024 · Same journal
Mkk7 Protects Against Cardiac Dysfunction in Heart Failure with Preserved Ejection Fraction · International Journal of Drug Discovery and Pharmacology · 2024 · Same journal
Human Cardiac Organoids: Quantification and Qualification in Cardiovascular Studies · International Journal of Drug Discovery and Pharmacology · 2024 · Same journal
Current Management of Erectile Dysfunction · International Journal of Drug Discovery and Pharmacology · 2025 · Same journal